Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments

by de Gruijl, Tanja D. , Spanholtz, Jan , Verheul, Henk M. W. , Veluchamy, John P. , van der Vliet, Hans J. , Kok, Nina

in adoptive natural killer cell therapy / Adoptive transfer / allogeneic natural killer cells / Antitumor activity / Apoptosis / autologous natural killer cells / Breast cancer / Cancer / Cancer immunotherapy / Cancer therapies / Cells / Clinical trials / Cytokines / Cytotoxicity / Effector cells / Graft versus host disease / Hematology / hematopoietic stem cell transplantation / Immunology / Immunotherapy / Kidney cancer / Ligands / Lymphocytes / Medical research / Metastasis / natural killer cell biotech companies / natural killer cell combinatorial studies / Natural killer cells / Oncology / Transplants & implants / Tumor necrosis factor-TNF / Tumors

2017

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments

by de Gruijl, Tanja D. , Spanholtz, Jan , Verheul, Henk M. W. , Veluchamy, John P. , van der Vliet, Hans J. , Kok, Nina

2017

Confirm

Do you wish to request the book?

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments

by de Gruijl, Tanja D. , Spanholtz, Jan , Verheul, Henk M. W. , Veluchamy, John P. , van der Vliet, Hans J. , Kok, Nina

2017

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments

de Gruijl, Tanja D.,

Spanholtz, Jan,

Verheul, Henk M. W.,

Veluchamy, John P.,

van der Vliet, Hans J.,

Kok, Nina

2017

Overview

Natural killer (NK) cells are critical immune effector cells in the fight against cancer. As NK cells in cancer patients are highly dysfunctional and reduced in number, adoptive transfer of large numbers of cytolytic NK cells and their potential to induce relevant antitumor responses are widely explored in cancer immunotherapy. Early studies from autologous NK cells have failed to demonstrate significant clinical benefit. In this review, the clinical benefits of adoptively transferred allogeneic NK cells in a transplant and non-transplant setting are compared and discussed in the context of relevant NK cell platforms that are being developed and optimized by various biotech industries with a special focus on augmenting NK cell functions.

Share this book

Add to My Shelf

Publisher

Frontiers Media SA,Frontiers Media S.A

Subject

adoptive natural killer cell therapy

/ Adoptive transfer

/ allogeneic natural killer cells

/ Antitumor activity

/ Apoptosis

/ autologous natural killer cells

/ Breast cancer